跳至主要内容
临床试验/RBR-10qpynpd
RBR-10qpynpd进行中(未招募)Unknown

Development and evaluation of a pharmaceutical system containing Caffeine for the treatment of Gynoid Lipodystrophy

Faculdade de Farmácia da Universidade Federal do Rio de Janeiro0 个研究点开始时间: 2023年12月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20Y 至 40Y(—)
性别
Female

入选标准

  • Female participant; participant between 20 and 40 years old; with gynoid lipodystrophy grade II or III in thighs and/or glutes bilaterally; with a body mass index between 18.5 and 29.9 kg/m2

排除标准

  • Skin infection; an inflammatory process on the skin; cancerous lesions; psoriasis; active acne; active herpes; in other procedures; in other procedures during the last 6 months; allergic to any asset used; pregnancy or breastfeeding; restrictive diet for weight loss; athlete or high-performance sports

研究者

发起方
Faculdade de Farmácia da Universidade Federal do Rio de Janeiro

相似试验